Market revenue in 2022 | USD 3.5 million |
Market revenue in 2030 | USD 7.5 million |
Growth rate | 10% (CAGR from 2022 to 2030) |
Largest segment | 13-24 weeks |
Fastest growing segment | 0-12 weeks |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | 0-12 weeks, 13-24 weeks, 25-36 weeks |
Key market players worldwide | CooperSurgical, Natera Inc, Eurofins Scientific SE, Illumina Inc, Centogene NV Ordinary Shares, MedGenome, Myriad Genetics Inc, Roche Holding AG, Qiagen NV, Labcorp Holdings Inc, Quest Diagnostics Inc, Biora Therapeutics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non invasive prenatal testing market will help companies and investors design strategic landscapes.
13-24 weeks was the largest segment with a revenue share of 51.43% in 2022. Horizon Databook has segmented the Kuwait non invasive prenatal testing market based on 0-12 weeks, 13-24 weeks, 25-36 weeks covering the revenue growth of each sub-segment from 2018 to 2030.
The Ministry of Health of Kuwait is responsible for the regulation of laboratory tests in the country. For entry into Kuwait, a company must apply for marketing authorization submitted to the Ministry of Health for evaluation and approval.
Furthermore, products used for diagnosis must meet the product & technical class-specific provisions in the Gulf Health Guidelines and should be registered with competent authorities, such as the EMA & U.S. FDA.
Kuwait’s public sector accounts for more than 80% of the total healthcare spending in the country. GIGKuwait is a major provider of a wide range of family and individual insurance policies across the country. This insurance coverage guarantees the necessary medical care in terms of accommodation, health needs, and treatment under a comprehensive insurance plan.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait non invasive prenatal testing market , including forecasts for subscribers. This country databook contains high-level insights into Kuwait non invasive prenatal testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account